Adcock Ingram first-half profits weighed down by sector issues
Performance was affected by constrained consumer spending in the lower living standard measures
20 February 2025 - 10:06
Pharmaceutical group Adcock Ingram has reported lower profits at the halfway stage of the financial year, with the group’s operational and financial performance affected by sector-specific factors.
Revenue for the six months to end-December decreased 0.6% to R4.7bn, due to a slowdown in both the independent and pharmaceutical wholesale channels, the latter having reduced their average inventory holdings on a number of key brands, the group said on Thursday...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.